Dr. Leary's Concord Prison Experiment: A 34-Year Follow-up Study
Journal of Psychoactive Drugs December 1, 1998 DOI: 10.1080/02791072.1998.10399715 via OpenAlex
Summary
AI-generated from the abstractA long-term follow-up to the Concord Prison Experiment (1961–1963) examined criminal justice records of 21 of the original 32 prisoners who received psilocybin-assisted group psychotherapy. The follow-up found that earlier published claims of reduced recidivism were erroneous. The original researchers had emphasized the need for comprehensive post-release group support, but such services were not sufficiently provided. Whether a new program combining psilocybin-assisted therapy with post-release support could lower recidivism remains an open empirical question.
Study at a glance
| Characteristics | Long-term follow-up study Peer reviewed |
|---|---|
| Sample size | 21 |
| Population | Prisoners from the original Concord Prison Experiment |
| Intervention | psilocybin-assisted group psychotherapy |
| Topics | Psychedelic-assisted therapy |
| Keywords | Psilocybin treatment Hallucinogen therapy Psychedelic medicine Prisoner rehabilitation |
| Citations | 29 |
| Key finding | Published claims of a treatment effect from psilocybin-assisted group psychotherapy in reducing recidivism were erroneous. |
Abstract
This study is a long-term follow-up to the Concord Prison Experiment, one of the best-known studies in the psychedelic psychotherapy literature. The Concord Prison Experiment was conducted from 1961 to 1963 by a team of researchers at Harvard University under the direction of Timothy Leary. The original study involved the administration of psilocybin-assisted group psychotherapy to 32 prisoners in an effort to reduce recidivism rates. This follow-up study involved a search through the state and federal criminal justice system records of 21 of the original 32 subjects, as well as personal interviews with two of the subjects and three of the researchers: Timothy Leary, Ralph Metzner and Gunther Weil. The results of the follow-up study indicate that published claims of a treatment effect were erroneous. This follow-up study supports the emphasis in the original reports on the necessity of embedding psilocybin-assisted psychotherapy with inmates within a comprehensive treatment plan that includes post-release, nondrug group support programs. Despite substantial efforts by the experimental team to provide post-release support, these services were not made sufficiently available to the subjects in this study. Whether a new program of psilocybin-assisted group psychotherapy and post-release programs would significantly reduce recidivism rates is an empirical question that deserves to be addressed within the context of a new experiment.